LETTER
Development of a Dual Fries–Claisen Sequence
1823
13709. (e) Assimomytis, N.; Sariyannis, Y.; Stavropoulos,
G.; Tsoungas, P. G.; Varvounis, G.; Cordopatis, P. Synlett
2009, 2777.
to the Fries–Claisen protocol (Scheme 4), yielding ad-
vanced product 17 which was then converted by acid-
mediated lactonization8 into the known pyranonaphtho-
quinone 18.9 The pyranonaphthoquinones are an interest-
ing class of naturally occurring antibiotic compound that
also display a wide range of other biological activities,
such as antifungal, antiviral, and anticancer activity.10 Our
current work on the application of this novel dual Fries–
Claisen rearrangement strategy to the synthesis of pyra-
nonaphthoquinone natural product targets will be reported
in due course.
(4) Green, I. R.; Nefdt, S.; Hugo, V. I.; Snijman, P. W. Synth.
Commun. 1994, 24, 3189.
(5) 6-Benzyloxy-1,4-dihydroxynaphthalene was prepared by
a route analogous to that used to access the 6-methoxy
derivative described in detail in: Masquelin, T.; Hengartner,
U.; Streith, J. Synthesis 1995, 780.
(6) Sibi, M. P.; Dankwardt, J. W.; Snieckus, V. J. Org. Chem.
1986, 51, 273.
(7) General Procedure for the Fries–Claisen
Rearrangements: Claisen Rearrangement of 8
4-(Allyloxy)-8-(benzyloxy)naphthalen-1-yl dimethyl
carbamate (8, 1.0 g, 2.65 mmol) was heated under reflux in
mesitylene (10 mL) for 24 h. The solvent was removed under
reduced pressure to yield a tarry brown solid. The crude solid
was dissolved in hexanes (30 mL) and placed under reduced
pressure in order to azeotropically remove any residual
mesitylene. The resulting solid was filter-washed with cold
hexane (30 mL) to yield 9 as a dark brown solid (793 mg,
79%); mp 89–91 °C. IR (thin film, CH2Cl2): 3416, 1634,
1262 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.58, 2.75, 3.26
(2 H, d, J = 6.4 Hz), 5.10 (2 H, s), 5.11–5.12 (1 H, m), 5.15
(1 H, q, J = 2.0 Hz), 5.90–5.97 (1 H, m), 6.14 (1 H, s), 6.74
(1 H, s), 6.82 (1 H, d, J = 7.6 Hz), 7.20 (1 H, t, J = 8.4 Hz),
7.36–7.49 (5 H, m), 7.65 (1 H, d, J = 8.4 Hz). 13C NMR (100
MHz, CDCl3): δ = 34.3, 35.7, 36.4, 70.7, 106.5, 115.0,
116.2, 119.1, 120.1, 121.5, 125.0, 126.9, 128.0, 128.2, 128.5
(2 C), 129.2, 136.2, 137.0, 139.6, 147.0, 154.4, 156.3.
HRMS–FAB: m/z calcd for C23H23NO4: 377.1627; found:
377.1621 [M+].
O
OMe
i–iv
NMe2
OMe
16
O
NMe2
O
OMe
v
OMe
17
O
O
O
O
O
OMe
18
Scheme 4 Reagents and conditions: i, s-BuLi, TMEDA, THF,
–78 °C (92%); ii, NaH, MeI, THF, 20 °C, 4 h (80%); iii, mesitylene,
reflux 3 h (92%); iv, K2CO3, MeI, acetone reflux, 24 h, 83%; v, 6 M
HCl aq, heat, 24 h (59%).
Fries Rearrangement of 12
4-(Allyloxy)-8-(benzyloxy)-1-methoxy-N,N-dimethyl-2-
naphthamide (12, 1.68 g, 4.30 mmol) was heated to 160 °C
in mesitylene, and the reaction was monitored by 1H NMR
analysis. After 3 h the mesitylene was removed by eva-
poration under reduced pressure. The crude tarry brown
solid was dissolved in hexanes and placed under reduced
pressure in order to azeotropically remove any residual
mesitylene. This process was repeated three times to give a
light brown solid which was chromatographed on silica gel,
eluting with light PE–EtOAc (1:1), to give 13 as a white
solid (1.28 g, 76%); mp 169–170 °C. IR (ATR): 1594, 1570,
1261, 1058 cm–1. 1H NMR (300 MHz, CDCl3): δ = 2.82 (3
H, s), 3.16 (3 H, s), 3.24 (1 H, dd, J = 7.2, 16.2 Hz), 3.37 (1
H, dt, J = 1.8, 16.2 Hz), 3.73 (3 H, s), 5.12–5.18 (2 H, m),
5.22 (2 H, q, J = 12.0 Hz), 5.87–5.99 (1 H, m), 6.22 (1 H, s),
6.92 (1 H, d, J = 7.8 Hz), 7.31–7.43 (4 H, m), 7.54 (2 H, d,
J = 6.9 Hz), 7.81 (1 H, dd, J = 0.6, 8.4 Hz). 13C NMR (100
MHz, CDCl3): δ = 32.3, 34.6, 38.5, 63.7, 71.3, 108.2, 115.2,
116.2, 117.1, 119.7, 126.0, 127.5 (2 C), 127.8, 128.5 (2 C),
128.7, 129.0, 135.6, 137.0, 145.8, 146.8, 155.0, 169.4.
HRMS (EI, CI): m/z calcd for C24H25NO4: 392.1856; found:
392.1853 [MH+].
Acknowledgment
We thank EPSRC for financial support of this project
(EP/F026552/1), Keele and Loughborough Universities for faci-
lities and financial support, and the EPSRC Mass Spectrometry Ser-
vice Centre (Swansea) for HRMS data.
References and Notes
(1) For a range of examples, see: (a) Cambie, R. C.; Zhen-Dong,
H.; Noall, W. I.; Rutledge, P. S.; Woodgate, P. D. Aust. J.
Chem. 1981, 34, 819. (b) Beauregard, D. A.; Cambie, R. C.;
Higgs, K. C.; Rutledge, P. S.; Woodgate, P. D. Aust. J.
Chem. 1994, 47, 1321. (c) Kotha, S.; Mandal, K.; Deb,
A. C.; Banerjee, S. Tetrahedron Lett. 2004, 45, 9603.
(d) Chattopadhyay, S. K.; Biswas, T.; Maity, S. Synlett
2006, 2211.
(2) Kotha, S.; Mandal, K. Tetrahedron Lett. 2004, 45, 2585.
(3) For a range of examples, see: (a) Sibi, M. P.; Snieckus, V.
J. Org. Chem. 1983, 48, 1935. (b) Sibi, M. P.;
(8) Sibi, M. P.; Jalil Miah, M. A.; Snieckus, V. J. Org. Chem.
1984, 49, 737.
(9) Hugo, V. I.; Oosthuizen, F. J.; Green, I. R. Synth. Commun.
2003, 33, 1425.
Chattopadhyay, S.; Dankwardt, J. W.; Snieckus, V. J. Am.
Chem. Soc. 1985, 107, 6312. (c) Singh, K. J.; Collum, D. B.
J. Am. Chem. Soc. 2006, 128, 13753. (d) Riggs, J. C.; Singh,
K. J.; Yun, M.; Collum, D. B. J. Am. Chem. Soc. 2008, 130,
(10) Uno, H. J. Org. Chem. 1986, 51, 350.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2012, 23, 1821–1823